Medtronic has positive Evolut TAVR data
Medtronic (NYSE: MDT) today reported two different datasets that support its Evolut transcatheter aortic valve replacement (TAVR) system.
Stay updated with breaking news from Structural Heart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Medtronic (NYSE: MDT) today reported two different datasets that support its Evolut transcatheter aortic valve replacement (TAVR) system.
The McLeod Heart and Vascular Institute combined the skills of Structural Heart Cardiologists Dr. Ravi Parikh and Dr. Brian Blaker with Cardiothoracic Surgeon Dr. Srinivas Kolla to repair a severely
Medtronic plc (NYSE:MDT) Q3 2024 Earnings Call Transcript February 20, 2024 Medtronic plc beats earnings expectations. Reported EPS is $1.3, expectations were $1.26. Medtronic plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Ryan Weispfenning: [Video Presentation] Good morning and welcome […]
Delivers on commitments with strong growth in Core Spine, Cardiac Surgery, Structural Heart, Cardiac Pacing, and across many international markets; Diabetes increases double digits as U.S. business...
Key Financial Highlights from Medtronic's Earnings Release